Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Chanda, Dipanjan ^a,j   Kim, Yong Hoon ^c   Li, Tiangang ^d   Misra, Jagannath ^a   Kim, Don Kyu ^a   Kim, Jung Ran ^f   Kwon, Joseph ^g   Jeong, Won Il ^h   Ahn, Sung Hoon ⁱ   Park, Tae Sik ^f   Koo, Seung Hoi ^e   Chiang, John Y L ^d   Lee, Chul Ho ^c   Choi, Hueng Sik ^a,b  

^a Chonnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Northeastern Ohio Medical University   (United States)

^e Korea University   (South Korea)

^f Gachon University College of Medicine   (South Korea)

^g Korea Basic Science Institute (KBSI)   (South Korea)

^h Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

ⁱ Korea Research Institute of Chemical Technology   (South Korea)

^j MAASTRICHT UNIVERSITY   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BILE ACID; CANNABINOID 1 RECEPTOR; LIVER PROTEIN; PROTEIN CB1R; PROTEIN CREBH; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE ACID METABOLISM; BILE ACID SYNTHESIS; DIABETES MELLITUS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; RAT;

ANIMALS; BILE ACIDS AND SALTS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ENDOCANNABINOIDS; ETHANOL; GENE DELETION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEP G2 CELLS; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MICE; MICE, INBRED C57BL; ORGAN SPECIFICITY; RECEPTOR, CANNABINOID, CB1; TRANSCRIPTIONAL ACTIVATION;

EID: 84880671539     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068845     Document Type: Article

References (43)

1. Pacher P, Bátkai S, Kunos G, (2006) The endocannabinoid system as an emerging target for pharmacotherapy. Pharmacol Rev 58: 389-462.
2. Matias I, Gonthier MP, Orlando P, Martiadis V, De Petrocellis L, et al. (2006) Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 91: 3171-3180.
3. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, et al. (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 115: 1298-1305.
4. Di Marzo V, Goparaju SK, Wang L, Liu J, Bátkai S, et al. (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822-825.
5. Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Janke J, et al. (2005) Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54: 2838-2843.
6. Blüher M, Engeli S, Klöting N, Berndt J, Fasshauer M, et al. (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55: 3053-3060.
7. Liu J, Zhou L, Xiong K, Godlewski G, Mukhopadhyay B, et al. (2012) Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. Gastroenterology 142: 1218-1228.
8. Tam J, Cinar R, Liu J, Godlewski G, Wesley D, et al. (2012) Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab. 16: 167-79.
9. Osei-Hyiaman D, Liu J, Zhou L, Godlewski G, Harvey-White J, et al. (2008) Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118: 3160-3169.
10. Wu J, Kaufman RJ, (2006) From acute ER stress to physiological roles of the Unfolded Protein Response. Cell Death Differ 13: 374-384.
11. Zhang K, Shen X, Wu J, Sakaki K, Saunders T, et al. (2006) Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 124: 587-599.
12. Vecchi C, Montosi G, Zhang K, Lamberti I, Duncan SA, et al. (2009) ER stress controls iron metabolism through induction of hepcidin. Science 325: 877-880.
13. Lee JH, Giannikopoulos P, Duncan SA, Wang J, Johansen CT, et al. (2011) The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism. Nat Med. 17: 812-5.
14. Zhang C, Wang G, Zheng Z, Maddipati KR, Zhang X, et al. (2012) Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice. Hepatology 55: 1070-82.
15. Lee MW, Chanda D, Yang J, Oh H, Kim SS, et al. (2010) Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. Cell Metab 11: 331-339.
16. Chanda D, Kim DK, Li T, Kim YH, Koo SH, et al. (2011) Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes. J Biol Chem. 286: 27971-9.
17. Chanda D, Kim YH, Kim DK, Lee MW, Lee SY, et al. (2012) Activation of cannabinoid receptor type 1 (CB1R) disrupts hepatic insulin receptor signaling via CREBH-mediated induction of Lipin1. J Biol Chem. 287: 38041-9.
18. Chiang JY, (2002) Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev. 23: 443-463.
19. Hofmann AF, (2009) Bile Acids: Trying to Understand Their Chemistry and Biology with the Hope of Helping Patients. Hepatology 49: 1403-1418.
20. Aranha MM, Cortez-Pinto H, Costa A, da Silva IB, Camilo ME, et al. (2008) Bile acid levels are increased in the liver of patients with steatohepatitis. Eur J Gastroenterol Hepatol. 20: 519-525.
21. Tung BY, Carithers RL Jr, (1999) Cholestasis and alcoholic liver disease. Clin Liver Dis. 3: 585-601.
22. Li T, Francl JM, Boehme S, Ochoa A, Zhang Y, et al. (2012) Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J Biol Chem. 287: 1861-73.
23. Li T, Matozel M, Boehme S, Kong B, Nilsson LM, et al. (2011) Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis. Hepatology 53: 996-1006.
24. Nestel PJ, Simons LA, Homma Y, (1976) Effects of ethanol on bile acid and cholesterol metabolism. Am J Clin Nutr. 29: 1007-1015.
25. Axelson M, Mörk B, Sjövall J, (1991) Ethanol has an acute effect on bile acid biosynthesis in man. FEBS Lett. 281: 155-159.
26. Nilsson LM, Sjövall J, Strom S, Bodin K, Nowak G, et al. (2007) Ethanol stimulates bile acid formation in primary human hepatocytes. Biochem Biophys Res Commun. 364: 743-747.
27. Song KH, Ellis E, Strom S, Chiang J, (2007) Hepatocyte growth factor signaling pathway inhibits cholesterol 7alpha-hydroxylase and bile acid synthesis in human hepatocytes. Hepatology 46: 1993-2002.
28. Park YJ, Qatanani M, Chua SS, LaRey JL, Johnson SA, et al. (2008) Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis. Hepatology 47: 1578-1586.
29. Kim I, Ahn SH, Inagaki T, Choi M, Ito S, et al. (2007) Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res. 48: 2664-72.
30. Jeong WI, Osei-Hyiaman D, Park O, Liu J, Bátkai S, et al. (2008) Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7: 227-235.
31. Kim DK, Kim YH, Jang HH, Park J, Kim JR, et al. (2012) Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol. Gut 62: 1044-54.
32. Waszkiewicz N, Szajda SD, Zalewska A, Konarzewska B, Szulc A, et al. (2009) Binge drinking-induced liver injury. Hepatology 50: 1676-1679.
33. Chen G, Ma C, Bower KA, Shi X, Ke Z, Luo J, (2008) Ethanol promotes endoplasmic reticulum stress-induced neuronal death: involvement of oxidative stress. J Neurosci Res. 86: 937-946.
34. Lee AH, Scapa EF, Cohen DE, Glimcher LH, (2008) Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320: 1492-1496.
35. Oyadomari S, Harding HP, Zhang Y, Oyadomari M, Ron D, (2008) Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab 7: 520-532.
36. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461.
37. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, et al. (2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313: 1137-1140.
38. Rutkowski DT, Wu J, Back SH, Callaghan MU, Ferris SP, et al. (2008) UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. Dev Cell. 15: 829-840.
39. Bochkis IM, Rubins NE, White P, Furth EE, Friedman JR, et al. (2008) Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress. Nat Med. 14: 828-836.
40. Ozawa K, Miyazaki M, Matsuhisa M, Takano K, Nakatani Y, et al. (2005) The Endoplasmic Reticulum Chaperone Improves Insulin Resistance in Type 2 diabetes. Diabetes 54: 657-663.
41. Nakatani Y, Kaneto H, Kawamori D, Yoshiuchi K, Hatazaki M, et al. (2005) Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem. 280: 847-851.
42. Nguyen P, Leray V, Diez M, Serisier S, Le Bloc'h J, et al. (2008) Liver lipid metabolism. J. Anim. Physiol. Anim. Nutr. 92: 272-283.
43. Ji C, Mehrian-Shai R, Chan C, Hsu YH, Kaplowitz N, (2005) Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcohol Clin Exp Res 29: 1496-1503.